prodchem
Aug 13, 2026
BASF's second-quarter 2026 performance provides an important intelligence checkpoint for assessing whether the chemical giant's earnings recovery is becoming more durable or remains heavily influenced by temporary market factors.
The headline numbers were strong. BASF reported Q2 EBITDA before special items of €2.45 billion, up approximately 54% year over year and well ahead of analyst expectations. First-half EBITDA before special items reached €4.805 billion, an increase of €715 million from the prior-year period.
More importantly, BASF had already responded to the stronger operating performance by raising its full-year 2026 EBITDA-before-special-items outlook to €6.9 billion–€7.7 billion, compared with the previous €6.2 billion–€7.0 billion range.
That makes the key question less about whether BASF will raise guidance and more about how much of the Q2 strength can realistically carry into the second half of the year.
BASF's Q2 performance was not simply a result of one isolated accounting item.
The company said earnings increased in nearly all segments, with stronger prices and higher volumes contributing to the improvement. Materials, Industrial Solutions and Agricultural Solutions significantly exceeded analyst expectations, while Nutrition & Care also slightly outperformed.
That distinction matters because operating earnings are a much better indicator of underlying performance than BASF's headline net income.
BASF's Q2 net income reached approximately €5.1 billion, but that figure was heavily affected by a roughly €3.9 billion pretax gain from the completed Coatings transaction with Carlyle.
For assessing full-year guidance, therefore, EBITDA before special items is the more useful metric.
The answer to the central intelligence question is clear: BASF has already revised its full-year guidance upward.
The company now expects:
2026 EBITDA before special items: €6.9 billion–€7.7 billion
Previous outlook: €6.2 billion–€7.0 billion
2025 actual: approximately €6.6 billion
2026 analyst consensus cited by BASF at the time of the preliminary update: approximately €7.3 billion
2026 free cash flow: still expected at €1.5 billion–€2.3 billion
So the Q2 beat has already translated into a meaningful change in management's expectations.
The interesting part now is whether BASF eventually moves toward the upper half of that €6.9 billion–€7.7 billion range.
The midpoint of BASF's EBITDA guidance moved from:
€6.6 billion → €7.3 billion
That represents an increase of roughly €700 million, or about 10.6% at the midpoint.
That is a meaningful upgrade for a company of BASF's scale.
It also moves the midpoint above the approximately €6.6 billion achieved in 2025, indicating that BASF now expects underlying earnings to improve year over year rather than merely recover to the prior year's level.
Through the first half of 2026, BASF generated €4.805 billion of EBITDA before special items.
That means the company has already generated roughly:
69.6% of the low end of its new full-year guidance
65.8% of the midpoint
62.4% of the high end
The second half therefore needs to generate approximately:
€2.095 billion to reach the low end
€2.495 billion to reach the midpoint
€2.895 billion to reach the high end
This is where the sustainability question becomes interesting.
BASF does not need another Q2-sized quarter to achieve the midpoint. It needs roughly €2.5 billion across Q3 and Q4 combined.
That gives the company some room for normalization.
Before the results, BASF's analyst estimates showed average Q2 EBITDA before special items of approximately €2.082 billion.
Actual Q2 EBITDA before special items came in at approximately €2.449 billion.
That is a beat of roughly €367 million, or about 18% versus the average estimate.
EBIT before special items showed a similar pattern:
Analyst average: approximately €1.081 billion
Actual Q2: approximately €1.5 billion
That puts the EBIT-before-special-items beat at roughly €419 million, or nearly 39% above consensus.
The magnitude of the operating beat explains why the guidance upgrade was relatively substantial.
Featured Product
BASF's headline profit growth can look spectacular.
Net income in Q2 was approximately €5.1 billion, compared with just €79 million in the prior-year quarter.
However, that does not mean BASF's underlying earnings power increased by more than sixty times.
The major reason was the Coatings transaction, which generated a substantial disposal gain.
This is precisely why investors should separate:
Reported net income
from
EBITDA before special items
when evaluating the sustainability of BASF's 2026 earnings.
The former received a major one-time boost. The latter reflects the operating performance that management actually uses for its full-year outlook.
Several elements of the Q2 improvement look more encouraging.
BASF's Q2 sales increased partly because higher prices contributed materially to growth.
If pricing strength persists, it can provide genuine earnings support.
Volumes also increased, indicating that the improvement was not purely price-driven.
That is another positive signal for underlying demand.
BASF continues implementing restructuring and cost-saving measures, with significant progress reported during the first half.
Cost savings can provide a more durable earnings contribution than temporary commodity-price movements.
The completion of the Coatings transaction and other portfolio actions are changing the composition of BASF's earnings base.
That makes year-over-year comparisons more complicated, but potentially improves capital allocation.
Several factors deserve caution.
BASF has maintained that geopolitical uncertainty remains significant.
The company specifically kept its broader earnings range unchanged despite raising the EBITDA-before-special-items outlook because of continuing geopolitical uncertainties.
BASF's Q2 operating cash flow was pressured by higher working capital requirements associated with higher raw material prices.
That means higher prices can simultaneously support revenue while creating cash-flow pressure.
Supply disruptions linked to the Middle East have been an important factor affecting the broader chemical industry.
Such disruptions can temporarily tighten supply and support prices and margins.
The question is whether those market conditions persist long enough to become embedded in BASF's full-year earnings.
BASF's current analyst estimates provide another useful reference point.
The average Q3 estimate is approximately:
Sales: €15.536 billion
EBITDA before special items: €1.528 billion
EBIT before special items: €524 million
That Q3 EBITDA expectation is considerably below the €2.449 billion recorded in Q2.
This suggests analysts already expect substantial normalization after the exceptionally strong second quarter.
That is actually an important clue.
The market does not appear to be assuming that Q2's earnings rate will simply repeat.
At the midpoint of €7.3 billion, BASF needs approximately €2.495 billion of EBITDA before special items in H2.
If Q3 comes in near the current €1.53 billion analyst estimate, BASF would need approximately €0.97 billion in Q4 to reach the midpoint.
That looks achievable based purely on the mathematics.
To reach the upper end of €7.7 billion, however, the company would need approximately €2.895 billion in H2.
After a €1.53 billion Q3, that would imply roughly €1.37 billion in Q4.
So the high end requires a stronger second half than the midpoint, but it does not require another Q2-sized earnings quarter.
For BASF, the next question is not simply revenue growth.
It is how much profit BASF retains from every additional euro of sales.
That means analysts should track:
EBITDA margin
Pricing versus raw-material costs
Volume growth
Fixed-cost savings
Capacity utilization
Product mix
Segment profitability
A recovery driven primarily by pricing can reverse quickly if feedstock costs catch up.
A recovery supported by pricing, volumes and structural cost reductions is considerably more durable.
BASF reported higher earnings in nearly all segments during Q2.
That broad-based improvement is encouraging.
However, the company also noted that Chemicals and Surface Technologies were significantly below analyst expectations even though the group overall exceeded consensus.
That means the group-level beat masks differences between individual businesses.
For investors, the composition of future earnings may therefore matter more than the headline group number.
The Chemicals segment sits close to the center of BASF's upstream industrial exposure.
Its performance is especially important because it is sensitive to:
Global industrial demand
Feedstock costs
Energy prices
Production utilization
Regional supply-demand balances
Commodity pricing
A sustained improvement in this segment would provide stronger evidence that BASF's earnings recovery is becoming structural.
BASF is simultaneously working through a major restructuring and portfolio transformation.
The company reported that workforce reductions and restructuring measures continued to progress, while asset and portfolio measures also advanced.
This matters because the earnings recovery does not need to come entirely from stronger chemical markets.
Part of the improvement can potentially come from BASF becoming a leaner company.
That makes cost discipline one of the most important variables to monitor through 2026 and 2027.
Despite the strong earnings performance, BASF's Q2 free cash flow was approximately negative €0.2 billion.
That compared with positive free cash flow of €0.5 billion in Q2 2025.
The main issue was higher capital tied up in working capital, particularly as raw-material prices increased.
This is an important warning against judging the recovery entirely through earnings.
Profit is improving faster than cash generation.
That gap deserves monitoring.
The upgrade itself provides evidence that management believes the improvement has enough durability to justify a higher forecast.
But BASF did not simply extrapolate Q2's performance across the remainder of the year.
Instead, it raised the range while retaining a relatively wide spread between €6.9 billion and €7.7 billion.
That wide range reflects uncertainty.
In other words:
Management is more confident about the earnings floor, but not completely confident about the ceiling.
A further guidance increase would become more likely if BASF sees:
Continued strong pricing
Sustained volume growth
Further fixed-cost reductions
Stable or improving feedstock spreads
Continued Middle East-related supply tightness
Strong Materials and Industrial Solutions performance
Better-than-expected Agricultural Solutions earnings
Conversely, normalization in pricing or weaker industrial demand could keep BASF closer to the lower half of its range.
The biggest risks include:
Rapid normalization of chemical prices
Weaker global manufacturing demand
Higher energy costs
Additional geopolitical disruptions
Currency headwinds
Weak downstream demand
Higher working-capital requirements
BASF itself continues to emphasize geopolitical uncertainty in its outlook.
That makes the upper end of the range harder to treat as a base case.
The current range can be interpreted in three scenarios.
This would imply that a meaningful portion of Q2's exceptional strength normalizes during the second half.
This represents a balanced outcome in which stronger first-half earnings are retained but Q2's exceptional conditions moderate.
This would require stronger-than-expected second-half operating performance and greater persistence in pricing, volumes and cost savings.
The midpoint of the new guidance is approximately €7.3 billion.
That is also very close to BASF's analyst consensus at the time of the initial guidance upgrade.
This means the market has broadly absorbed the initial upgrade.
The next earnings surprise therefore needs to come from BASF delivering above the €7.3 billion midpoint rather than simply achieving the newly revised range.
The next major intelligence checkpoint will be Q3.
Investors should compare:
Actual Q3 EBITDA before special items
against
approximately €1.53 billion current analyst consensus.
If BASF beats that number while maintaining pricing and volume momentum, the upper half of its full-year guidance could become increasingly credible.
If Q3 falls substantially below expectations, the market may begin questioning whether Q2 represented a temporary peak.
BASF's earnings also provide useful signals for industrial chemical buyers.
Procurement teams should monitor:
Chemical pricing trends
Feedstock costs
Regional supply tightness
Capacity utilization
BASF's restructuring-related asset changes
Production availability
Logistics disruptions
A stronger earnings environment can sometimes coincide with tighter supplier pricing power.
That makes BASF's operating results relevant not only to investors but also to customers negotiating chemical supply contracts.
The most important conclusion is that BASF has already answered the guidance question with a raise.
The company increased its 2026 EBITDA-before-special-items outlook from €6.2 billion–€7.0 billion to €6.9 billion–€7.7 billion following its strong Q2 performance.
The harder question is now whether the company can reach the upper half of that new range.
The evidence is mixed but constructive.
On the positive side:
Q2 operating earnings significantly exceeded expectations
First-half EBITDA before special items reached €4.805 billion
Higher prices and volumes supported earnings
Most segments improved
Restructuring is contributing to efficiency
On the cautionary side:
Q2 free cash flow was negative
Geopolitical uncertainty remains high
Some important segments still underperformed expectations
The Q2 net-income surge was heavily influenced by a one-time disposal gain
Analysts already expect a significant Q3 earnings normalization
BASF's Q2 2026 performance represents a genuine improvement in underlying operating earnings, but it should not be confused with a 167% sustainable jump in recurring profitability.
The most useful benchmark is EBITDA before special items.
On that basis, BASF delivered approximately €2.45 billion in Q2, up roughly 54% year over year, and subsequently raised its full-year outlook to €6.9 billion–€7.7 billion.
The first-half result of €4.805 billion means BASF has already completed most of the work needed to reach the lower end of its revised range.
The real intelligence test now moves to the second half.
If pricing, volumes and restructuring benefits remain strong, BASF could move toward the upper end of its guidance. If Q2's market tailwinds fade, the midpoint may prove to be the more realistic outcome.
For investors, the key question is therefore no longer “Will BASF raise guidance?”
It already has.
The question is:
“How much of the Q2 earnings beat survives after the temporary tailwinds fade?”
That will make Q3 and Q4 the decisive tests of whether BASF's 2026 earnings recovery represents a cyclical rebound—or the beginning of a more durable improvement in profitability.
BASF's Q2 2026 EBITDA before special items rose approximately 54% to €2.45 billion, significantly exceeding analyst expectations.
First-half EBITDA before special items reached €4.805 billion, up €715 million year over year.
BASF already raised its 2026 EBITDA-before-special-items guidance to €6.9 billion–€7.7 billion, from €6.2 billion–€7.0 billion.
The midpoint of the revised range is approximately €7.3 billion, above 2025's €6.6 billion.
Q2 net income was boosted heavily by the Coatings disposal gain, making EBITDA before special items the better measure of recurring performance.
Higher prices, stronger volumes and restructuring benefits provide evidence that some of the earnings improvement is sustainable.
Geopolitical uncertainty, raw-material costs and weaker cash conversion remain important risks.
The next major test is Q3, where current analyst consensus calls for approximately €1.53 billion of EBITDA before special items.
Found this useful?
Continue Reading
Shinsung Materials has patented technology for producing and stabilizing water-soluble UV filters, targeting a key formulation challenge in sunscreen and personal care products. The innovation could support more stable specialty ingredients for formulators and buyers.
Petrochemical gains have strengthened earnings at major producers as Middle East supply disruptions tighten global markets. Buyers and investors now face a key question: can stronger pricing and margins survive into 2027?
Rising cracking margins are reinforcing the same supply dynamics supporting polymer producers as damaged Middle East capacity tightens global availability. Buyers now face a market where feedstock economics, operating rates and regional supply risks increasingly move together.
